Evidence map›Paper›PMID 24330691›Full record

Trial reportClinical and translational science2013

Sildenafil increases muscle protein synthesis and reduces muscle fatigue.

Melinda Sheffield-Moore, John E Wiktorowicz, Kizhake V Soman, Christopher P Danesi, Michael P Kinsky, Edgar L Dillon, Kathleen M Randolph, Shannon L Casperson, Dennis C Gore, Astrid M Horstman and 11 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical and translational science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06290713 (Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06290713 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)

TypeinterventionalSponsorUniversity of FloridaRan2024 to 2026Enrolled50ConditionsDuchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in ChildrenArmsTadalafil, Placebo, Exercise Training
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Increased cGMP improves microvascular exercise training adaptations in diet-induced obesity.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  6. Article
  7. Phosphodiesterase 5a Signalling in Skeletal Muscle Pathophysiology.International journal of molecular sciences · 2022
    Article
  8. Nitric oxide and skeletal muscle contractile function.Nitric oxide : biology and chemistry · 2022
    Review
  9. Article
  10. An Overview of NO Signaling Pathways in Aging.Molecules (Basel, Switzerland) · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2018
    Article
  16. Article
  17. Review
  18. The maintenance ability and CaExperimental & molecular medicine · 2016
    Article
  19. Amino Acid Sensing in Skeletal Muscle.Trends in endocrinology and metabolism: TEM · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Melinda Sheffield-MooreDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
John E Wiktorowicz
Kizhake V Soman
Christopher P Danesi
Michael P Kinsky
Edgar L Dillon
Kathleen M Randolph
Shannon L Casperson
Dennis C Gore
Astrid M Horstman
James P Lynch
Barbara M Doucet
Joni A Mettler
Jeffrey W Ryder
Lori L Ploutz-Snyder
Jean W Hsu
Farook Jahoor
Kristofer Jennings
Gregory R White
Susan D McCammon
William J Durham
The University of Texas Medical Branch at Galveston · USChildren's Nutrition Research Center at Baylor College of Medicine · USUniversities Space Research Association · US

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Nutrition and Anabolic Interventions in Cancer CachexiaR01CA127971 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SHEFFIELD-MOORE, MELINDA · 2008 to 2014
$1.8M
Muscle Perfusion and Protein Metabolism in ElderlyR01AG021539 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SHEFFIELD-MOORE, MELINDA · 2003 to 2009
$1.8M
NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1TR000071NCI NIH HHS 5R01CA127971NCI NIH HHS R01 CA127971NIA NIH HHS 5P30-AG024832NIA NIH HHS P30 AG024832NIA NIH HHS R01 AG021539NIA NIH HHS R01 AG21539
6 · The paper itself

Abstract

Reductions in skeletal muscle function occur during the course of healthy aging as well as with bed rest or diverse diseases such as cancer, muscular dystrophy, and heart failure. However, there are no accepted pharmacologic therapies to improve impaired skeletal muscle function. Nitric oxide may influence skeletal muscle function through effects on excitation-contraction coupling, myofibrillar function, perfusion, and metabolism. Here we show that augmentation of nitric oxide-cyclic guanosine monophosphate signaling by short-term daily administration of the phosphodiesterase 5 inhibitor sildenafil increases protein synthesis, alters protein expression and nitrosylation, and reduces fatigue in human skeletal muscle. These findings suggest that phosphodiesterase 5 inhibitors represent viable pharmacologic interventions to improve muscle function.

Indexed as

AdultAgedCyclic GMPDouble-Blind MethodDrug Administration ScheduleHumansMaleMiddle AgedMuscle ContractionMuscle FatigueMuscle, SkeletalNitric OxidePhosphodiesterase 5 InhibitorsPiperazinesProtein BiosynthesisPurinesCyclic GMPNitric OxidePhosphodiesterase 5 InhibitorsPiperazinesPurinesSildenafil CitrateSulfonesexercisemetabolismprotein S-nitrosylationtranslational research

Identifiers

PMID24330691
PMCPMC4076819
OpenAlexW1911483882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.